Past NextLevel Pharma Webinars

Neurodegenerative diseases are one of the most heavily researched areas in medical science world-wide. Every day, researchers involved in the treatments for such diseases make discoveries that can advance the discovery and development of therapeutics. However, the sharing of the knowledge of such potentially ground-breaking work is often limited by the researchers' geographical locations, overly restrictive scientific journals, and not sharing the work with the right audience. Therefore, it is becoming increasingly difficult for potential stakeholders to become aware of these advances and remain updated. Emerging technologies in genetics, personal medicine, computer modelling, medical imaging, and stem cell research have been combined to give rise to promising new CNS treatments. Not only have there been significant advances in the methods used to prevent the progression of neurodegenerative diseases, there have also been discoveries that may be able to regenerate neurons in the brain and spinal cord.

This webinar series showcases the work of international scientists from all over the world that are working in the fields of neurodegenerative diseases, spinal cord injuries, regenerative medicine, and CNS drug optimization. Hear first-hand accounts from both internationally renowned institutions and enterprises with less publicity. Several of these presenters are open to potential partnerships and collaborations. Learn about the latest research being done on the drug discovery and development for Parkinson’s, Alzheimer’s, multiple sclerosis, ALS and also platform technologies that are applicable to a variety of such diseases. Also get informed on the latest innovations in CNS regeneration research and how this promising research contributes to overcoming the challenges of brain and spinal cord repair.

This webinar includes the following presentations:

• Non-mammalian models of Parkinson's Disease (PD) for Drug Discovery
• Advanced Mouse Models of Hemorrhagic Stroke and Multiple Sclerosis: New Insights into Future Drug Development
• Strategies in Success for Small Molecule CNS Drug Discovery: How Molecular Properties Data Mining Can Reveal Key Considerations in Drug Design
• Structure-Based Discovery of Novel Adenosine A2a Antagonists for the Treatment of Parkinson's Disease
• Personalised Medicine Comes to Neurology
• Novel Biomarkers for Alzheimer's Disease
• Leptin as a Novel Hormone Replacement Therapy for Alzheimer's Disease
• A Novel Assay for Early Amyloid Oligomer Formation Reveals a New Class of Potential AD Therapeutics
• Autophagy and Neurodegeneration
• Controlled Differentiation of Stem Cells After Transplantation
• Taxol Induces Axon Regeneration in the Lesioned CNS
• Human Neural Cells in 3D Environment: From Brain-Like Tissue Models to Functional Grafts
• The Use of Polymer Hydrogels in Spinal Cord Repair
• Isolation of a Novel Rat Neural Precursor Clone that Efficiently Gives Rise to Functional GABAergic Neurons in Culture
• Directed Use of Glia in CNS Regenerative Therapies
• ALS Challenges and Emerging Regeneration Methods

The recordings of these webinars are available for purchase. For more details, please contact us at webinars(at)nextlevelpharma.com

13. Susanna Narkilahti - Human Neural Cells in 3D Environment: From Brain-Like Tissue Models to Functional Grafts